Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e63f9c08d5310a499cc2ba4c83cb4b10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5de9a1dac6b033c4643bb236ef4df3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-14122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-11023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-10023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-14023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-14123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-14134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-12023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16022 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
filingDate |
2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba13a12abfec3c0f6a5a79819914f29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c24fb77a7c0f6bf3918d192fad2f21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d8538f6df5fce375c930e62320f65e |
publicationDate |
2018-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018183443-A1 |
titleOfInvention |
Vlp-based monovalent ebola vaccines and methods of making and using same |
abstract |
Disclosed herein are virus-like particle (VLP)-based monovalent vaccine compositions. The compositions may comprise a spherical retroviral Group- specific Antigen ("Gag") protein core and a single Ebola glycoprotein selected from either a Zaire (EBOV) glycoprotein or a Sudan (SUDV) glycoprotein. The Ebola glycoprotein may be incorporated into the surface of the spherical Gag core, wherein said VLP-based vaccine presents a single Ebola glycoprotein antigen. |
priorityDate |
2017-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |